Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated:  3/27/2017
Clinical Research Facility
mi
from
Nashville, TN
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated: 3/27/2017
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated:  3/27/2017
Clinical Research Facility
mi
from
El Paso, TX
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated: 3/27/2017
Clinical Research Facility
mi
from
El Paso, TX
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated:  3/27/2017
Clinical Research Facility
mi
from
San Antonio, TX
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated: 3/27/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated:  3/27/2017
mi
from
Ponce,
Phase 2 Study to Evaluate Safety & Efficacy of VPI-2690B in Diabetic Nephropathy Patients
A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group, Phase 2, Two-Part Adaptive Study to Evaluate the Safety and Efficacy of VPI-2690B Injection in Patients With Nephropathy Due to Diabetes
Status: Enrolling
Updated: 3/27/2017
mi
from
Ponce,
Click here to add this to my saved trials
Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer
The Gambro Polyflux HD-C4 Small Ease of Use Study
Status: Enrolling
Updated:  4/4/2017
Advanced Dialysis Center
mi
from
Lanham, MD
Ease of Use Study for the Gambro Polyflux HD-C4 Small Dialyzer
The Gambro Polyflux HD-C4 Small Ease of Use Study
Status: Enrolling
Updated: 4/4/2017
Advanced Dialysis Center
mi
from
Lanham, MD
Click here to add this to my saved trials
Isotonic Solution Administration Logistical Testing
Isotonic Solution Administration Logistical Testing: Pilot Study for the Isotonic Solutions and Major Adverse Renal Events Trial
Status: Enrolling
Updated:  4/19/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Isotonic Solution Administration Logistical Testing
Isotonic Solution Administration Logistical Testing: Pilot Study for the Isotonic Solutions and Major Adverse Renal Events Trial
Status: Enrolling
Updated: 4/19/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10028
mi
from
Birmingham, AL
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10028
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10021
mi
from
Phoenix, AZ
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10021
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10001
mi
from
Los Angeles, CA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10001
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10021
mi
from
Palo Alto, CA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10021
mi
from
Palo Alto, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US01089
mi
from
San Diego, CA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US01089
mi
from
San Diego, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10035
mi
from
San Francisco, CA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10035
mi
from
San Francisco, CA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10002
mi
from
Aurora, CO
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10002
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10012
mi
from
Atlanta, GA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10012
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10036
mi
from
Augusta, GA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10036
mi
from
Augusta, GA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10013
mi
from
Chicago, IL
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10013
mi
from
Chicago, IL
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10046
mi
from
Lexington, KY
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10046
mi
from
Lexington, KY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10048
mi
from
New Orleans, LA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10048
mi
from
New Orleans, LA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10011
mi
from
Baltimore, MD
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10011
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US00005
mi
from
Ann Arbor, MI
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US00005
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10078
mi
from
Saint Louis, MO
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10078
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10019
mi
from
Livingston, NJ
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10019
mi
from
Livingston, NJ
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US00009
mi
from
Buffalo, NY
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US00009
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10047
mi
from
New York, NY
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10047
mi
from
New York, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10019
mi
from
The Bronx, NY
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10019
mi
from
The Bronx, NY
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10025
mi
from
Chapel Hill, NC
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10025
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US00153
mi
from
Charlotte, NC
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US00153
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10016
mi
from
Durham, NC
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10016
mi
from
Durham, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10050
mi
from
Greenville, NC
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10050
mi
from
Greenville, NC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10072
mi
from
Cincinnati, OH
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10072
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10005
mi
from
Cleveland, OH
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10005
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10027
mi
from
Harrisburg, PA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10027
mi
from
Harrisburg, PA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10048
mi
from
Pittsburgh, PA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10048
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10014
mi
from
Charleston, SC
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10014
mi
from
Charleston, SC
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10022
mi
from
Memphis, TN
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10022
mi
from
Memphis, TN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10016
mi
from
Nashville, TN
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10016
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10002
mi
from
Dallas, TX
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10002
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10076
mi
from
Fort Worth, TX
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10076
mi
from
Fort Worth, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10009
mi
from
Houston, TX
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10009
mi
from
Houston, TX
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10046
mi
from
Salt Lake City, UT
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10046
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US10017
mi
from
Charlottesville, VA
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US10017
mi
from
Charlottesville, VA
Click here to add this to my saved trials
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  4/20/2017
Site US00009
mi
from
Madison, WI
A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
A Phase 2a, Randomized, Open-label, Active Control, Multi-Center Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 4/20/2017
Site US00009
mi
from
Madison, WI
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Birmingham, AL
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Little Rock, AR
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Iowa City, IA
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Louisville, KY
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Baltimore, MD
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated:  4/25/2017
Clinical Research Facility
mi
from
Kansas City, MO
Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism
An Open-label, Single-arm Study to Assess the Safety & Tolerability of Cinacalcet in Addition to Standard of Care in Pediatric Subjects Age 28 Days to < 6 Yrs With Chronic Kidney Disease & Secondary Hyperparathyroidism Receiving Dialysis
Status: Enrolling
Updated: 4/25/2017
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials